Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer. - Wikidata - wikimedia - TriplyDB

Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer.

Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer.

http://www.wikidata.org/entity/Q42153300

about

Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors Prognostic value of FGFR gene amplification in patients with different types of cancer: a systematic review and meta-analysis.Fibroblast Growth Factor Receptor 1 Gene Amplification in Nonsmall Cell Lung Cancer Molecular Testing of Lung Cancers Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer.Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapy.Fibroblast growth factor receptor 1 amplification in non-small cell lung cancer by quantitative real-time PCR Correlation of WWOX, RUNX2 and VEGFA protein expression in human osteosarcoma Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps.Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage disease.PIK3CA mutations in non-small cell lung cancer (NSCLC): genetic heterogeneity, prognostic impact and incidence of prior malignancies.FGFR1 amplifications in squamous cell carcinomas of the lung: diagnostic and therapeutic implications.Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma.Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method.Targeted next generation sequencing of parotid gland cancer uncovers genetic heterogeneity.The clinical pathological characteristics and prognosis of FGFR1 gene amplification in non-small-cell lung cancer: a meta-analysis.Fibroblast growth factor receptor 3 protein is overexpressed in oral and oropharyngeal squamous cell carcinoma.Targeted therapy for squamous cell lung cancer.EGFR protein expression using a specific intracellular domain antibody and PTEN and clinical outcomes in squamous cell lung cancer patients with EGFR-tyrosine kinase inhibitor therapy.Oncogene and therapeutic target analyses in atypical fibroxanthomas and pleomorphic dermal sarcomas Genetic alteration profiling of patients with resected squamous cell lung carcinomas.Prognostic implications of FGFR1 and MYC status in esophageal squamous cell carcinoma.Fibroblast Growth Factor Receptor 1 (FGFR1), Partly Related to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) and Microvessel Density, is an Independent Prognostic Factor for Non-Small Cell Lung Cancer Fibroblast growth factor receptor (FGFR) alterations in squamous differentiated bladder cancer: a putative therapeutic target for a small subgroup.MDM2 and CDK4 amplifications are rare events in salivary duct carcinomas Receptor tyrosine kinase alterations and therapeutic opportunities in squamous cell carcinoma of the lung.Prognostic and predictive biomarkers in lung cancer. A review.Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung.Targeting FGFR in Squamous Cell Carcinoma of the Lung.Activated cdc42-associated kinase is up-regulated in non-small-cell lung cancer and necessary for FGFR-mediated AKT activation.A genomics-based classification of human lung tumors.MET gene copy number alterations and expression of MET and hepatocyte growth factor are potential biomarkers in angiosarcomas and undifferentiated pleomorphic sarcomas.Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression.Complexity of FGFR signalling in metastatic urothelial cancer.Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target.A Phase Ib Study of Alpelisib (BYL719), a PI3Kα-Specific Inhibitor, with Letrozole in ER+/HER2- Metastatic Breast Cancer.High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients.Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) to select the optimal patients for matched therapy?

P2860

Q26998790-AC7FD577-6CA9-4CFD-9172-1FF02CCE1092 Q27853061-A2E407AB-5486-4661-AB5A-34D225038FE2 Q28077032-224A97C1-1D4B-41E1-A787-4E269DCA4EDD Q33729715-30997171-B78E-4E4A-A945-94663E78179B Q33750128-C5A9BADE-6652-45B7-AD2E-2F9114CB25FE Q35000497-9468D44D-F9A6-4BA1-8B15-486A5A881834 Q35047444-DD7D1A90-4705-432F-8B56-D83B94A2A070 Q35065555-A647E499-90E8-4EE8-B4D9-C277BD1E2BE4 Q35084915-02637F5F-9F26-41A0-91B5-DE36C34A7231 Q35149263-8553E421-6FEA-4D78-9FBC-B3A73500F453 Q35176080-E643D7E7-F789-4965-AE19-02DED96E5ED7 Q35206634-BA7E7499-27C4-4BD3-8FDF-E7C71EDF1607 Q35273802-5E6A7F40-4F48-4DE4-A6A6-556518F06977 Q35743009-8EEB1FEF-721F-4C63-A51C-B6B61022043D Q35837391-D51B37E0-F205-4AF6-8988-6D16FF357D28 Q35842078-D1EAB234-1F64-4BCF-AFCD-9B37B02DCAF5 Q36228558-F76ADB7A-1615-433E-8E2A-1AE26333BD9E Q36450685-DF5D6B6D-73D9-4B90-A85C-DCE358BE8410 Q36528389-A67DAADA-E42D-4BEC-91F3-4A3F6F0B9390 Q37096910-D05E28EA-A918-4A7B-821A-35F180DAB8C9 Q37204247-77D406C0-818C-473D-ACE9-F2430C03002D Q37225394-A4531DAF-AF25-466B-8495-E0437FC6528E Q37392781-A45FBCF2-A0E8-497F-862C-FFCBD3ABB75C Q37444264-CA84A6E3-EDB9-4EB1-84C2-D8EB9C08807A Q37603125-E2BD71E2-4384-4745-80CF-858378BA945C Q37687627-8BB93768-EC5F-4A00-AEEE-80C04DC95324 Q37688930-1AE73138-86B5-438E-AC85-87CC3237BE74 Q38130137-056B470C-1398-46A6-8C61-2EC92F44CB21 Q38178187-E16FF88C-BA2D-4F28-8A70-E579DAF59BB5 Q38390024-BBB02EDD-703F-468A-B835-9397A9AFDC35 Q38690050-C7180669-0CA0-413A-849E-FAD1A5BD0781 Q38878596-2757658A-0190-48C1-8165-0AED23681DE0 Q39123357-17F8CCED-A613-46E8-93B9-8AC7A0945963 Q39286355-4A18E97A-17F8-4019-9B9F-85C53811F2E1 Q40343596-9632DAE3-4EE1-4923-AA24-4AA914997497 Q40396999-0FA1FF9E-2DBB-435F-AA87-0791F6D50A71 Q40770256-BD2E990E-E791-4EFF-8CF5-E142EAF96357 Q47141006-25B94795-BC61-45A2-9C1E-CC121A80146E Q47141559-EBFA4883-CF47-4678-868D-98EDE26A2898 Q47164059-892C0C85-6206-4CFD-A0FF-18B843A5B136

P2860

Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer.

http://www.wikidata.org/entity/Q42153300

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Definition of a fluorescence i ...... in squamous cell lung cancer.

@en

Definition of a fluorescence i ...... in squamous cell lung cancer.

@nl

type

label

Definition of a fluorescence i ...... in squamous cell lung cancer.

@en

Definition of a fluorescence i ...... in squamous cell lung cancer.

@nl

prefLabel

Definition of a fluorescence i ...... in squamous cell lung cancer.

@en

Definition of a fluorescence i ...... in squamous cell lung cancer.

@nl

P1433

Q42153300-15031AB3-83C4-4FE7-975F-8188FFD21843

P1476

Q42153300-DCE3D992-4302-45CB-B247-86BAD0EF2AAF

P2093

Q42153300-0347334C-EAE7-43A4-B7D7-16DBA839FCF1

Q42153300-038F9581-9023-409C-B22D-0193323353BE

Q42153300-096A1145-0F9D-4FC0-8638-BF036FBA8B53

Q42153300-13291A61-21E5-44A7-956A-64190BF96D3F

Q42153300-215F11F8-194B-4C8B-A9D2-DD30BE7D6D70

Q42153300-229D8A6A-BFC5-47C4-A0E5-BD4A181CD287

Q42153300-23716E80-B2DC-4DF1-8260-7D07B3FA89D9

Q42153300-498A375E-0FC4-419C-8959-A68F7D90BC33

Q42153300-53A15F83-4397-4C4C-B5C4-5433B425EECA

Q42153300-60FB4EA2-7E13-47B0-BDC2-D40B0AE67815

P2860

Q42153300-00C63D9C-A57F-480A-9171-AD7FA1196BF9

Q42153300-07D19FF4-B112-4F39-90B7-B6BE14C8A3C2

Q42153300-1183080E-6CA9-48C9-87C2-46D117E59C64

Q42153300-25DBB0FD-8A7F-4703-AD24-D6E25130296C

Q42153300-29B639D8-5207-4497-8806-8A1B54481862

Q42153300-2AFC211B-63E1-4EE1-8A6E-EB3E3BF89E69

Q42153300-4BB91536-C32B-44FA-A251-A509A8B54ACD

Q42153300-54A6313D-0FBA-4E9E-B4E5-1FABD40DFD30

Q42153300-7398AB7C-16A7-4641-A5F6-D1D8CC652B9D

Q42153300-8C48E389-D05D-4EB7-B817-A7A74E94D900

P2888

Q42153300-84739965-A8D1-4305-86A4-09DED58C8FBF

P304

Q42153300-E59EE612-B53E-42FE-8BFD-64F964A0F20E

P31

Q42153300-1116338C-F8CE-4858-A17F-48DD6AA77D9B

P356

Q42153300-FFD6D0DB-2F0E-4DB5-8281-3DC2D7B00FC3

P433

Q42153300-AC727C61-9568-49C1-B0E5-E0ED3FD9F671

P478

Q42153300-6CBDCA21-2C1D-42DC-9F56-7092763E6309

P50

Q42153300-D004E0E3-08A8-468C-876C-0D828CA647D8

Q42153300-F2C86BB0-78F9-4B57-8B55-46E02BDD04C2

P577

Q42153300-86F29E78-5AFF-40A0-9D41-89B21DE200A4

P5875

Q42153300-1A2E6281-04AE-48C3-9F29-D66A5AA9AB7E

P6179

Q42153300-01E8A9ED-1B9E-405F-A9F1-D7C938774B6E

P698

Q42153300-9C36ABE1-D5F6-48D5-9B44-8B6D51B0A2F0

P932

Q42153300-982B0739-1BFC-425E-90D9-CA8EE708AA49

P356

MODPATHOL.2012.102

P1433

Modern Pathology

P1476

Definition of a fluorescence i ...... s in squamous cell lung cancer

@en

P2093

Andreas Schlesinger

http://www.w3.org/2001/XMLSchema#string

Christian Mattonet

http://www.w3.org/2001/XMLSchema#string

Elke Binot

http://www.w3.org/2001/XMLSchema#string

Ellen Paggen

http://www.w3.org/2001/XMLSchema#string

Erich Stoelben

http://www.w3.org/2001/XMLSchema#string

Friederike Göke

http://www.w3.org/2001/XMLSchema#string

Hans-Ulrich Schildhaus

http://www.w3.org/2001/XMLSchema#string

Jürgen Wolf

http://www.w3.org/2001/XMLSchema#string

Katja Schmitz

http://www.w3.org/2001/XMLSchema#string

Kerstin Albus

http://www.w3.org/2001/XMLSchema#string

P2860

Cellular signaling by fibroblast growth factor receptors

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.

Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.

Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Fibroblast growth factor signalling: from development to cancer

SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

P2888

modpathol.2012.102

P304

1473-1480

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.2012.102

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Lukas C Heukamp

Katarina Riesner

P577

2012-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225286861

http://www.w3.org/2001/XMLSchema#string

P6179

1046670140

http://www.w3.org/2001/XMLSchema#string

P698

22684217

http://www.w3.org/2001/XMLSchema#string

P932

4089812

http://www.w3.org/2001/XMLSchema#string